{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T05:33:24Z","timestamp":1770442404039,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":2993,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.7861\/clinmedicine.16-1-66","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T06:19:47Z","timestamp":1454307587000},"page":"66-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Atopic eczema"],"prefix":"10.1016","volume":"16","author":[{"given":"Sara J","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.7861\/clinmedicine.16-1-66_bib1","series-title":"Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization","author":"Johansson","year":"2003"},{"key":"10.7861\/clinmedicine.16-1-66_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2133.2006.07185.x","article-title":"A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases","volume":"155","author":"Beattie","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.7861\/clinmedicine.16-1-66_bib3","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMcp042803","article-title":"Clinical practice","volume":"352","author":"Williams","year":"2005","journal-title":"Atopic dermatitis. N Engl J Med"},{"key":"10.7861\/clinmedicine.16-1-66_bib4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/jid.2011.393","article-title":"One remarkable molecule: filaggrin","volume":"132","author":"Brown","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.7861\/clinmedicine.16-1-66_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra1011040","article-title":"Filaggrin mutations associated with skin and allergic diseases","volume":"365","author":"Irvine","year":"2011","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmedicine.16-1-66_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/all.12246","article-title":"Nonallergic comorbidities of atopic eczema: an overview of systematic reviews","volume":"69","author":"Deckert","year":"2014","journal-title":"Allergy"},{"key":"10.7861\/clinmedicine.16-1-66_bib7","article-title":"House dust mite reduction and avoidance measures for treating eczema","volume":"1","author":"Nankervis","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.7861\/clinmedicine.16-1-66_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/dtb.2007.09.0015","article-title":"why use them?","volume":"45","author":"No authors listed","year":"2007","journal-title":"Drug Ther Bull"},{"key":"10.7861\/clinmedicine.16-1-66_bib9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/bjd.12505","article-title":"The European TREatment of severe Atopic eczema in children Taskforce (TREAT) survey","volume":"169","author":"Proudfoot","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.7861\/clinmedicine.16-1-66_bib10","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jaci.2013.03.016","article-title":"Systemic therapies for severe atopic dermatitis in children and adults","volume":"132","author":"Flohr","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.7861\/clinmedicine.16-1-66_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/ced.12591","article-title":"What\u2019s new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 2. Treatment and prevention","volume":"40","author":"Madhok","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.7861\/clinmedicine.16-1-66_bib12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Kong","year":"2012","journal-title":"Genome Res"},{"key":"10.7861\/clinmedicine.16-1-66_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1743","article-title":"Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris","volume":"38","author":"Smith","year":"2006","journal-title":"Nat Genet"},{"key":"10.7861\/clinmedicine.16-1-66_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nature Genet"},{"key":"10.7861\/clinmedicine.16-1-66_bib15","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jaci.2009.03.036","article-title":"Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease","volume":"123","author":"Rodriguez","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.7861\/clinmedicine.16-1-66_bib16","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jaci.2014.12.013","article-title":"Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year","volume":"135","author":"Kelleher","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.7861\/clinmedicine.16-1-66_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaci.2014.08.005","article-title":"Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention","volume":"134","author":"Simpson","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.7861\/clinmedicine.16-1-66_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmedicine.16-1-66_bib19","article-title":"Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial","author":"Thaci","year":"2015","journal-title":"Lancet"},{"key":"10.7861\/clinmedicine.16-1-66_bib20","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1101\/gr.191320.115","article-title":"The intersection of microbiome and host at the skin interface: genomic- and metagenomic-based insights","volume":"25","author":"Grice","year":"2015","journal-title":"Genome Res"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824027477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824027477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmedicine.16-1-66","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:37:48Z","timestamp":1761460668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824027477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1470211824027477"],"URL":"https:\/\/doi.org\/10.7861\/clinmedicine.16-1-66","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atopic eczema","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmedicine.16-1-66","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2016. All rights reserved.","name":"copyright","label":"Copyright"}]}}